Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment

NCT02501382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2019-06-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of hyperic oxygen treatment on the immune response in patients with necrotizing soft tissue infections

Conditions

  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Gas Gangrene
  • Fournier Gangrene

Sponsors & Collaborators

  • Ole Hyldegaard

    lead OTHER

Principal Investigators

  • Ole Hyldegaard, MD, PhD · Department of Anaesthesiology, Center of Hyperbaric Treatment, sect. 4092, Copenhagen University Hospital, Denmark

  • Marco Bo Hansen, MD · Department of Anaesthesiology, Center of Hyperbaric Treatment, sect. 4092, Copenhagen University Hospital, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-12-01
Completion
2015-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501382 on ClinicalTrials.gov